Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2006-11-17

FDA Approved: FLUOXETINE — Supplemental Application (TIME CAP LABORATORIES, INC.)

View source ↗

Summary

The FDA approved a supplemental application for a fluoxetine hydrochloride product from Time Cap Laboratories, Inc., approving this generic formulation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluoxetine hydrochloride (Fluoxetine hydrochloride)

Snippet

SUPPL AP for FLUOXETINE (FLUOXETINE HYDROCHLORIDE)